Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial

Joost van den Dool, Bart Visser, J Hans T M Koelman, Raoul H H Engelbert, Marina A J Tijssen, Joost van den Dool, Bart Visser, J Hans T M Koelman, Raoul H H Engelbert, Marina A J Tijssen

Abstract

Background: Cervical dystonia is characterized by involuntary muscle contractions of the neck and abnormal head positions that affect daily life activities and social life of patients. Patients are usually treated with botulinum toxin injections into affected neck muscles to relief pain and improve control of head postures. In addition, many patients are referred for physical therapy to improve their ability to perform activities of daily living. A recent review on allied health interventions in cervical dystonia showed a lack of randomized controlled intervention studies regarding the effectiveness of physical therapy interventions.

Methods/design: The (cost-) effectiveness of a standardized physical therapy program compared to regular physical therapy, both as add-on treatment to botulinum toxin injections will be determined in a multi-centre, single blinded randomized controlled trial with 100 cervical dystonia patients. Primary outcomes are disability in daily functioning assessed with the disability subscale of the Toronto Western Spasmodic Torticollis Rating Scale. Secondary outcomes are pain, severity of dystonia, active range of motion of the head, quality of life, anxiety and depression. Data will be collected at baseline, after six months and one year by an independent blind assessor just prior to botulinum toxin injections. For the cost effectiveness, an additional economic evaluation will be performed with the costs per quality adjusted life-year as primary outcome parameter.

Discussion: Our study will provide new evidence regarding the (cost-) effectiveness of a standardized, tailored physical therapy program for patients with cervical dystonia. It is widely felt that allied health interventions, including physical therapy, may offer a valuable supplement to the current therapeutic options. A positive outcome will lead to a greater use of the standardized physical therapy program. For the Dutch situation a positive outcome implies that the standardized physical therapy program forms the basis for a national treatment guideline for cervical dystonia.

Trial registration: Number Dutch Trial registration (Nederlands Trial Register): NTR3437.

Figures

Figure 1
Figure 1
Effect of BTX and expected additional effect of PT. Effect of BTX. Increasing lines indicate a better effect of BTX and less severity of CD, pain and disability to perform daily life tasks. Red lines illustrate the normal effect of BTX, blue dotted lines illustrate the expected additional effect of the PT program.

References

    1. Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. Mov Disord. 1987;2:332–358.
    1. Epidemiologic Study of Dystonia in Europe (ESDE) CollaborativeGroup. A prevalence study of primary dystonia in eight European countries. J Neurol. 2000;247:787–792. doi: 10.1007/s004150070094.
    1. Lowenstein DH, Aminoff MJ. The clinical course of spasmodic torticollis. Neurology. 1988;38:530–532. doi: 10.1212/WNL.38.4.530.
    1. Chan J, Brin M, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord. 1991;6:119–126. doi: 10.1002/mds.870060206.
    1. Jankovic J, Leder S, Warner D. et al.Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991;41:1088–1091. doi: 10.1212/WNL.41.7.1088.
    1. Kutvonen O, Dastidar P, Nurmikko T. Pain in spasmodic torticollis. Pain. 1997;69:286.
    1. Zetterberg L, Lindmark B, Soderlund A, Asenlof P. Self-Perceived non-motor aspects of cervical dystonia and their association with disability. J Rehabil Med. 2012;44:950–954. doi: 10.2340/16501977-1055.
    1. Cassidy A. Pathophysiology of Idiopathic Focal Dystonia. ACNR. 2010;10:14–18.
    1. Jankovic J, Brin M. Therapeutic uses of botulinum toxin. N Engl J Med. 1991;324:1186–1194. doi: 10.1056/NEJM199104253241707.
    1. Brashear A, Bergan K, Wojcieszek J. et al.Patients’ perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A. Mov Disord. 2000;15:150–153. doi: 10.1002/1531-8257(200001)15:1<150::AID-MDS1024>;2-X.
    1. Burgen ASV, Dickens F, Zatman LJ. The action of botulinum toxin on the neuromuscular junction. J Physiol. 1994;109:10–24.
    1. Truong D, Duane DD, Jankovic J. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomised double-blind placebo-controlled study. Mov Disord. 2005;20:783–791. doi: 10.1002/mds.20403.
    1. Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P. et al.Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2005;25(1):CD003633.
    1. Delnooz C, Horstink MWIM, Tijssen MA. Warrenburg van der BPC: Paramedical Treatment in Primary Dystonia: A Systematic Review. Mov Disord. 2009;24:2187–2198. doi: 10.1002/mds.22608.
    1. Tassoreli C, Mancini F, Balloni L, Pacchetti C, Sandrini G, Nappi G. et al.Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord. 2006;21:2240–2243. doi: 10.1002/mds.21145.
    1. El-Bahrawy MN, El-Tamawy MS, Shalaby NM, Abdel-Alim AM. Cervical dystonia: Abnormal head posture and its relation to hand function. Egypt J Neurol, Psychiatr Neurosurg. 2009;46:203–208.
    1. Queiroz MA, Chien HF, Sekeff-Sallem FA, Barbosa ER. Physical therapy program for cervical dystonia:a study of 20 cases. Funct Neurol. 2012;27:187–192.
    1. Bleton J-P. Physiotherapy of focal dystonia: A physiotherapist’s personal experience. Eur J Neurol. 2010;17(SUPPL 1):107–112.
    1. Shumway-Cook A, Woollacott MH. Motor control, translating research into clinical practice. 4. Wolters Kluwer Lippincott Williams & Wilkins; 2010.
    1. Kleim JA, Jones TA. Principles of expierence dependent neural plasticity: Implications for rehabilitation after brain damage. J Speech Lang Hear Res. 2008;51:s225–s239. doi: 10.1044/1092-4388(2008/018).
    1. AGREE next step consortium. AGREE II. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. 2001. .
    1. Tijssen MAJ, Dool Van Den J, Hillten Van JJ, Warrenburg Van Der BPC. DystonieNet. .
    1. Consky ES, Lang AE. In: Therapy with botulinum toxin. Jankovic J, Hallett M, editor. New York: Marcel Dekker; 1994. Clinical assessments of patients with cervical dystonia; pp. pp. 211–37.
    1. Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord. 1997;12:570–575. doi: 10.1002/mds.870120414.
    1. Jahanshahi M, Marsden CD. Body concept, disability and depression in patients with spasmodic torticollis. Behav Neurol. 1990;3:117–131.
    1. Tsui JK, Stoessl AJ, Eisen E, Calne S. Double blind study of botulin toxin in spasmodic torticollis. Lancet. 1986;2(8501):245–246.
    1. Guy W. In: ECDEU Assessment Manual for Psychopharmacology, revised. Guy W, editor. Rockville: MI: National Insitute of Mental Health; 1976. Clinical global impression; pp. 217–222.
    1. Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med. 2003;33:611–622. doi: 10.1017/S0033291703007414.
    1. Capuano-Pucci D, Rheault W, Aukai J. Intratester and intertester reliability of the cervical range of motion device. Arch Phys Med Rehab. 1991;72:340.
    1. Breivik EK, Bjornsson GA, Skovlund E. A comparison of pain rating scales by sampling from clinical trial data. Clin J Pain. 2000;16:22–28. doi: 10.1097/00002508-200003000-00005.
    1. Lundeberg T, Lund I, Dahlin L, Borg E, Gustafsson C, Sanda L. et al.Reliability and responsiveness of three different pain assesments. In J Rehabil Med. 2001;33:279–283. doi: 10.1080/165019701753236473.
    1. Muller J, Wissel J, Kemmler G, Voller B. Craniocervical dystonia questionnaire (CDQ-24):development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry. 2004;75:749–753. doi: 10.1136/jnnp.2003.013441.
    1. Brazier JE, Harper R, Jones NMB, O’Cathain AThomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160–164. doi: 10.1136/bmj.305.6846.160.
    1. Müller J, Kemmler G, Wissel J. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol. 2002;249:842–846. doi: 10.1007/s00415-002-0733-1.
    1. Beck TA, Epstein N, Brown G, Steer RA. An inventory to measure clinical anxiety: psychometric proportions. J Consult Clin Psychol. 1988;56:893–897.
    1. Beck TA, Steer RA, Garbin MG. Psychometric proportions of the Beck Depression Inventory: twenty five years of evaluation. Clin Psychol Rev. 1988;8:77–100. doi: 10.1016/0272-7358(88)90050-5.
    1. Fydrich T, Dowdall D, Chambless DL. Reliability and validity of the Beck Anxiety Inventory. J Anxiety Disord. 1992;6:55–61. doi: 10.1016/0887-6185(92)90026-4.
    1. Bouwmans C, Hakkaart-van Roijen L, Koopmanschap M, Krol M, Severens H, Brouwer W. Productivity Cost Questionnaire. Erasmus University Rotterdam: Institute for Medical Technology Assesment; 2013.
    1. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek: Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg College voor zorgverzekeringen. Erasmus University Rotterdam: Institute for Medical Technology Assessment; 2010.
    1. EuroQoL WorkGroup. EuroQol–a new facility for the measurement of healthrelated quality of life. Health Policy. 1990;16:199–208.
    1. Brans JWM, Lindeboom R, Aramideh M, Speelman JD. Longterm effects of botulinum toxin on impairment and functional health in cervical dystonia. Neurology. 1998;50:1461–1463. doi: 10.1212/WNL.50.5.1461.
    1. Brans JW, Lindeboom R, Snoek JW, Zwarts MJ, van Weerden TW, Brunt ER. et al.Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology. 1996;46:1066–1072. doi: 10.1212/WNL.46.4.1066.
    1. de Morree JJ. Dynamiek van het menselijk bindweefsel: functie beschadiging en herstel. Houten: Bohn Stafleu Van Loghum; 2001.
    1. Fung YC. Biomechanics. Mechanical properties of living tissues. New York: Springer Verlag; 1993.
    1. Shea JB, Morgan RL. Contextual interference effects on the acquisition, retention and transfer of a motor skill. In J Exp Psychol. 1979;5:179–187.
    1. Schmidt RA, Lee TD. Motor control and learning: a behavioral emphasis. Champaign, IL: Human Kinetics; 2005.
    1. Shea CH, Shebilske WL, Worchel S. Motor learning and control. Englewood Cliffs, NJ: Prentice-Hall; 1993.
    1. Fitts PM, Posner MI. Human performance. Belmont CA: Brooks/Cole; 1967.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner